248 related articles for article (PubMed ID: 23891187)
41. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
42. Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice.
Blais A; Drouin G; Chaumontet C; Voisin T; Couvelard A; Even PC; Couvineau A
PLoS One; 2017; 12(1):e0169908. PubMed ID: 28085909
[TBL] [Abstract][Full Text] [Related]
43. Orexin and central regulation of cardiorespiratory system.
Shahid IZ; Rahman AA; Pilowsky PM
Vitam Horm; 2012; 89():159-84. PubMed ID: 22640613
[TBL] [Abstract][Full Text] [Related]
44. Therapeutics development for addiction: Orexin-1 receptor antagonists.
Perrey DA; Zhang Y
Brain Res; 2020 Mar; 1731():145922. PubMed ID: 30148984
[TBL] [Abstract][Full Text] [Related]
45. Hypothalamic leptin-neurotensin-hypocretin neuronal networks in zebrafish.
Levitas-Djerbi T; Yelin-Bekerman L; Lerer-Goldshtein T; Appelbaum L
J Comp Neurol; 2015 Apr; 523(5):831-48. PubMed ID: 25421126
[TBL] [Abstract][Full Text] [Related]
46. Hypothalamus, hypocretins/orexin, and vigilance control.
Nishino S
Handb Clin Neurol; 2011; 99():765-82. PubMed ID: 21056227
[TBL] [Abstract][Full Text] [Related]
47. Orexins and orexin receptors: from molecules to integrative physiology.
Matsuki T; Sakurai T
Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
[TBL] [Abstract][Full Text] [Related]
48. Distribution of orexin/hypocretin immunoreactivity in the brain of a male songbird, the house finch, Carpodacus mexicanus.
Singletary KG; Deviche P; Strand C; Delville Y
J Chem Neuroanat; 2006 Dec; 32(2-4):81-9. PubMed ID: 16806811
[TBL] [Abstract][Full Text] [Related]
49. Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brain.
D'Almeida V; Hipólide DC; Raymond R; Barlow KB; Parkes JH; Pedrazzoli M; Tufik S; Nobrega JN
Brain Res Mol Brain Res; 2005 May; 136(1-2):148-57. PubMed ID: 15893599
[TBL] [Abstract][Full Text] [Related]
50. Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats.
Di Sebastiano AR; Wilson-Pérez HE; Lehman MN; Coolen LM
Horm Behav; 2011 Jan; 59(1):1-8. PubMed ID: 20851122
[TBL] [Abstract][Full Text] [Related]
51. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
[TBL] [Abstract][Full Text] [Related]
52. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.
Salin-Pascual RJ
Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826
[TBL] [Abstract][Full Text] [Related]
53. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
Kohlmeier KA; Inoue T; Leonard CS
J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
[TBL] [Abstract][Full Text] [Related]
54. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
Takahashi K; Lin JS; Sakai K
Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
[TBL] [Abstract][Full Text] [Related]
55. Orexin receptor antagonists--a patent review (2010 to August 2014).
Boss C
Expert Opin Ther Pat; 2014 Dec; 24(12):1367-81. PubMed ID: 25407283
[TBL] [Abstract][Full Text] [Related]
56. Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist.
Steiner MA; Gatfield J; Brisbare-Roch C; Dietrich H; Treiber A; Jenck F; Boss C
ChemMedChem; 2013 Jun; 8(6):898-903. PubMed ID: 23589487
[TBL] [Abstract][Full Text] [Related]
57. P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons.
Florenzano F; Viscomi MT; Mercaldo V; Longone P; Bernardi G; Bagni C; Molinari M; Carrive P
J Comp Neurol; 2006 Sep; 498(1):58-67. PubMed ID: 16856176
[TBL] [Abstract][Full Text] [Related]
58. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
59. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.
Sakurai T; Nagata R; Yamanaka A; Kawamura H; Tsujino N; Muraki Y; Kageyama H; Kunita S; Takahashi S; Goto K; Koyama Y; Shioda S; Yanagisawa M
Neuron; 2005 Apr; 46(2):297-308. PubMed ID: 15848807
[TBL] [Abstract][Full Text] [Related]
60. The role of orexin-A in food motivation, reward-based feeding behavior and food-induced neuronal activation in rats.
Choi DL; Davis JF; Fitzgerald ME; Benoit SC
Neuroscience; 2010 Apr; 167(1):11-20. PubMed ID: 20149847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
